Inventor · disambiguated record
James Hitchin
Also filed as: HITCHIN JAMES · HITCHIN JAMES R
7 granted patents·5 pending applications·10 citations·filing 2015–2024
77Inventor score
Top patents by PatentIndex Score
12 records- 0184US12129236B2PARG inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2021·Granted Oct 29, 2024·1 cites·14 claims
- 0284US10995073B2PARG inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2019·Granted May 4, 2021·3 cites·16 claims
- 0383US10508086B2PARG inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2015·Granted Dec 17, 2019·3 cites·12 claims
- 0482US2025223266A1Parg inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2024·Application pending·0 cites
- 0575US10654846B2Autotaxin inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2016·Granted May 19, 2020·2 cites·2 claims
- 0663US10239843B22,4-dioxo-quinazoline-6-sulfonamide derivatives as inhibitors of PARGCANCER RESEARCH TECH LTD·Filed 2015·Granted Mar 26, 2019·1 cites·18 claims
- 0754US11453666B2Autotaxin inhibitory compoundsCANCER RESEARCH TECH LTD·Filed 2020·Granted Sep 27, 2022·0 cites·20 claims
- 0849US2025129092A1Compounds useful in modulation of ahr signallingJAGUAHR THERAPEUTICS PTE LTD·Filed 2022·Application pending·0 cites
- 0945US12221439B2Tetrahydropyridopyrimidine derivatives as AhR modulatorsJAGUAHR THERAPEUTICS PTE LTD·Filed 2019·Granted Feb 11, 2025·0 cites·20 claims
- 1045US2023279000A1Pyridopyrimidine derivatives useful in modulation of ahr signallingJAGUAHR THERAPEUTICS PTE LTD·Filed 2021·Application pending·0 cites
- 1137US2021395242A1Heterocyclic compounds as ahr modulatorsJAGUAHR THERAPEUTICS PTE LTD·Filed 2019·Application pending·0 cites
- 1237US2023225991A1Compounds for use in the treatment of acute intermittent porphyriaVESTLANDETS INNOVASJONSSELSKAP AS·Filed 2020·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when James Hitchin files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →